Alethiomics is an Oxford University spin-out applying innovations in single-cell multi-omic analysis to the development of novel therapeutics for myeloproliferative neoplasms (MPNs). MPNs are a group of chronic blood cancers that begin with mutations occurring in cancer stem cells in the bone marrow. While currently available treatments can relieve symptoms, they do not tackle the […]

View post to subscribe to site newsletter.

Eradivir has developed a small molecule technology that tethers immune cells to diseased cells, with the potential to treat multiple viral diseases and cancers. Eradivir “MiniBITs” are small bispecific molecules that engage both a cytotoxic immune cell and a virus/virus-infected or cancer cell. Upon bridging between the two cell types, the immune cell is activated […]

View post to subscribe to site newsletter.

Protai has built an AI-based platform that maps the course of diseases on the protein level, enhancing the ability to observe cellular function and discover new drugs. By systematically mapping diseases on the protein level the company aims to create an entirely new layer of functional information that enables identification of therapeutic and diagnostic targets. […]

View post to subscribe to site newsletter.